Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4538_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
Introduction
https://t.me/medicina_free
PeterM.Baptista andGuillermoPlazaMayor
1.1 Introduction
Obstructive sleep apnea (OSA) is one of the most prevalent sleep disorders in the general population, with important pathophysiological sequelae that worsen the quality of life of patients, leading to an increase in trafc accidents and a higher mortality rate [1]. Therefore, early diagnosis and adequate treatment of OSA are of vital importance.
1.2 Sleep Disorders
Sleep is a physiological state to which the human being dedicates a third of his life. It is an active state, different from wakefulness, in which a series of physiological processes occur to maintain physical and mental balance.
Sleep is made up of a series of phases in 4–6cycles that repeat throughout 7–8h during the night. These phases are called REM (Rapid Eye Movement or rapid eye movement) and non-REM (non-Rapid Eye Movement). The representation of these is called hypnogram and is obtained by recording the brain electrical activity (elec­troencephalogram or EEG), eye movements (electrooculogram or EOG) and muscle activity (electromyogram or EMG).
Each sleep cycle consists of about 60–90min of non-REM sleep and 15–30min of REM sleep. By the age of 60, deep non-REM sleep starts to decrease, especially
1
P. M. Baptista (*) Clinica Universidad de Navarra, Pamplona, Spain
G. P. Mayor Hospital Universitario de Fuenlabrada, Hospital La Zarzuela, Madrid, Spain
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 P. M. Baptista et al. (eds.), Obstructive Sleep Apnea,
https://doi.org/10.1007/978-3-031-35225-6_1
1
2
https://t.me/medicina_free
in men, until it disappears, while REM sleep remains stable throughout life. Each phase of sleep has specic functions, and therefore, its deprivation entails a series of consequences.
Sleep-related disturbances have been observed in up to 15% of the current popu­lation. Given the progressive impact on health and the difcult management of all sleep disorders, the American Academy of Sleep Medicine (AASM) in 2004 con­sidered necessary a revision of the initial international classication of 1979 (ICSD international classication of sleep disorders [2].
This classication subdivided all disorders into two large blocks based on the patient’s main symptomatology: dyssomnias, for all those disorders that lead to insomnia or excessive daytime sleepiness, which may be caused by intrinsic or extrinsic factors, and parasomnias, disorders that occur during sleep, sleep without producing the two previous symptoms. The ICSD-2 already describes seven large blocks, one of them dedicated exclusively to sleep-disordered breathing, and the last changes of the ICSD in 2014 gave rise to a third edition (ICSD-3) with minimal differences from the previous one [3].
International classication of sleep disorders (ICSD-3 2015)
1. Insomnia
2. Sleep-associated breathing disorders (SBD)
3. Hypersomnia of central origin
4. Sleep-wake circadian rhythm disorders
5. Parasomnias
6. Sleep-related movement disorders
7. Other sleep disorders, subclassied in: (a) Medical and neurological disorders associated with sleep (b) Substance-induced sleep disorders
P. M. Baptista and G. P. Mayor
1.3 Sleep Breathing Disorders (SBD) andTheir
Differential Diagnosis
In the previous ICSD classications, SDBs belonged to the group of intrinsic sleep disorders. Currently, they constitute the second group of the ICSD-3 and can be summarized as follows [2, 4]:
1. Central sleep apnea syndromes (a) primary (b) secondary
2. Obstructive sleep apnea syndromes or Obstructive Sleep Apnea (OSA), previ-
ously known as OSAHS (obstructive sleep apnea–hypopnea syndrome) (a) in the adult (b) in the child
3. Hypoventilation disorders (a) idiopathic
1 Introduction
https://t.me/medicina_free
(b) central congenital (c) secondary
4. Sleep hypoxemia
5. Other nonspecic sleep-disordered breathing: (a) snoring (b) catathrenia
All these SBDs have in common a respiratory failure during sleep, which gener­ally leads to continuous oxygen desaturations and a series of clinical manifestations that will give rise to severe metabolic, neurological and cardiovascular sequelae [5].
Polysomnography (PSG) is considered the reference or gold standard sleep test [614]. It consists of recording neurophysiological and cardiorespiratory parame­ters during sleep. It allows us to classify the different respiratory events, distinguish pathological from physiological apneas, obstructive from central apneas, or demon­strate the transition from apnea to breathing, in any sleep position [14].
Currently the relatively high and increasing prevalence of OSA [15] and conse­quent economic burden and limited access to PSG has led to the development of less costly procedures like home sleep apnea testing (HSAT) for patients with suspected obstructive sleep apnea (OSA) and has become widespread [1618]. Clinical stud­ies have shown that HSAT when used in uncomplicated patients with a high prob­ability of moderate to severe OSA may provide similar diagnostic accuracy as PSG for moderate and severe OSA [19, 20]. Also, health care insurance companies and third-party payers accept HSAT diagnostic ndings for payment of treatment for OSA with CPAP in many countries [16, 21, 22].
Therefore, according to the AASM (American Association of Sleep Medicine), HSAT is recommended as an alternative to PSG for diagnosis of OSA only in medi­cally uncomplicated adult patients with a high pretest probability of moderate-to­severe OSA [23, 24]. With “medically uncomplicated” adult patients being dened as those with an absence of conditions associated with increased risk of nonobstruc­tive sleep-disordered breathing (SDB), including signicant cardiopulmonary dis­ease, potential respiratory muscle weakness due to neuromuscular conditions, history of stroke or chronic opioid use, and no potential indications of a signicant central sleep disorder, such as central sleep apnea, parasomnia, narcolepsy or severe insomnia [25].
3
1.4 Pathophysiology ofOSA
Under normal conditions, during sleep, there are changes in the caliber of the upper airway (UA) that lead to a reduction in airow with a stable airway in healthy patients but with a collapse in OSA patients with variable manifestations (Fig.1.1). These changes are due to three main factors [2630].
1. During non-REM sleep, hypotonia appears in the dilator muscles of the pharynx,
which are the ones that while awake, maintain the caliber of the upper airway. In
4
https://t.me/medicina_free
Fig. 1.1 Summary of consequences of OSA
P. M. Baptista and G. P. Mayor
patients with OSA, there is an airway collapse during inspiration, called dynamic collapse, due to negative pressures, and during expiration (static collapse) caused principally by muscular hypotonia.
2. Ventilatory function, lung volume and ventilatory response to hypoxia and
hypercapnia decrease. In the OSA patient, airway collapse produces a state of hypoxemia and hypercapnia, which stimulates chemoreceptors. This produces overexertion of the inspiratory muscles, which stimulate the mechanoreceptors, activating the CNS, ending in microarousals or arousals as a defense mechanism to resume correct breathing. These states of hypoxemia, hypercapnia and con­tinuous microarousals will give rise to a series of serious clinical consequences.
3. The anatomical reduction of the upper airway due to excess fat or small bony
structure, or other anatomical factors cause a reduction in the caliber of the air­way, and more so in a supine position. In patients with OSA, these anatomical factors, associated with general and functional characteristics, predispose to the collapse of the UA during sleep. Any structure of the UA that reduces the size of the pharyngeal lumen is also a factor that favors OSA.However, a narrower pharynx is not synonymous with OSA since women have a smaller UA than men and suffer from this problem less frequently, in a 2:1 ratio.
1.5 Phenotypes andEndotypes ofOSA
In the last decade, Eckert etal. have made progress in understanding the pathophysi­ology of OSA, describing at least four phenotypes/endotypes that contribute to its pathogenesis and opened new therapeutic alternatives aimed at more personalized medicine [3058].
The increased collapsibility of the UA is mainly due to the narrowing of the upper airway (anatomical factor). However, the fact that OSA does not occur during wakefulness demonstrates that it is not just an anatomical problem [30]. Thus, func­tional (nonanatomical) factors include:
• A lack of efcient muscle contraction during sleep (muscular factor).
1 Introduction
https://t.me/medicina_free
Fig. 1.2 Modication Eckert etal. [3035]: four types of phenotypes/endotypes
5
• Instability of respiratory control (respiratory control or loop gain).
• A low threshold for arousal (Fig.1.2).
The standard reference for quantifying airway alteration is done by calculating the collapse-inducing tissue pressure, the so-called critical collapse pressure (P
crit
[29]. It is dened as the minimum intraluminal pressure necessary to keep the col­lapsible segment of the UA open. However, a negative critical pressure character­izes normal UA.This P OSA.The increase in P
value is lower in normal subjects than in snorers and
crit
may be due to anatomical abnormalities or functional or
crit
nonanatomical abnormalities.
1.5.1 Anatomical Phenotype
The factors that reduce the caliber of the UA involve an increase in its resistance, generating negative pharyngeal pressure during inspiration that predisposes it to collapse. Undoubtedly, altered UA anatomy is a critical factor in OSA.Anatomical factors range from nasal obstruction (nasal valve, septal deviation, turbinates), cra­niofacial anomalies (size and shape), anomalies of the oral cavity (macroglossia, tonsillar hypertrophy, abnormal hard and soft palate congurations), alterations of the pharynx at its three levels (nasopharynx, oropharynx and hypopharynx) and laryngeal alterations.
)
6
https://t.me/medicina_free
In addition, anatomical factors have an impact on other factors (muscular and neurological response). Micrognathia, for example, moves the base of the tongue backward and interferes with the genioglossus’s muscular efciency. Obesity is the leading cause of decreased pharyngeal space since adipose tissue deposition in the regions surrounding the UA directly reduces pharyngeal space. Additionally, it has been shown that fatty deposits in specic places, such as the tongue, can play an essential role in the collapsibility of the UA.Obese individuals also tend to have lower lung volumes and signicantly lower functional residual capacity, which decreases the caudal traction of the trachea and predisposes to the collapse of the UA and its narrowing. Fat deposits between muscle bers have also been described in obese subjects, reducing their contractile capacity.
The UA’s size and shape also inuence the pharynx’s cross-sectional area. The smaller size of the craniofacial structures has shown to be a critical anatomical fac­tor in OSA patients of Asian descent. Additionally, other nonanatomical factors, such as edema, may be involved in the collapsibility of the UA and, consequently, in the appearance of obstructive events.
P. M. Baptista and G. P. Mayor
1.5.2 Muscle Factor
Far from being a rigid structure, the UA’s permeability depends mainly on its mus­cles’ dilator activity. Within the muscle factor, three key elements have been dened in the pathophysiology of OSA: Neural control, response and muscle efciency.
Given its location and participation in multiple functions (speech, swallowing and breathing), the neural control of the muscles is highly complex. The onset of sleep dramatically inuences the neural drive of these muscles. The primary dilator muscle of the UA, the genioglossus muscle, is mainly cyclically activated and receives neural input from the brainstem, the UA mechanoreceptors and changes in hypoxia and PaCO2. The sum of these impulses results in the activation of the genio­glossus muscle during inspiration to counteract the negative pressure exerted by the inspiratory muscles and thus to prevent the collapse of the UA.The onset of sleep and changes highly inuence this activity during the different sleep phases (progres­sively decreases during N1, N2 and REM, increases in N3). Other muscles, such as the tensor veli palatine, have a more tonic activity that decreases at the onset of sleep and is not as phase dependent. Apart from the neural response to sleep onset and its different sleep phases, the pharyngeal musculature can increase its activity in response to PaCO2 and pressure changes. This concept refers to muscle response. It has been reported that muscle activity does not increase in the face of obstruction in a third of patients with OSA.Finally, muscular efciency converts the neural input received by the airway dilator muscles into a contraction that will increase ow in response to an obstructive event.
Additionally, it has been shown that even within OSA patients, there are different patterns of muscle efcacy. While some patients have an adequate increase in mus­cle activity against obstruction (good muscle response) and good effectiveness in dilating the UAW, others show a low muscular response to obstruction and therefore
1 Introduction
https://t.me/medicina_free
fail to open the UA (low muscular efciency). Additionally, there are patients who, despite having an excellent muscular response, do not have UA dilation and there­fore have low muscular efciency.
In addition, the predominance in patients with OSA of type IIA muscle bers has been described, compared to type I, which presents little resistance to prolonged anaerobic efforts, signicantly reducing their performance during hypoxemia [50].
Therefore, a therapeutic option would be the “training” of these muscles through exercises proposed with myofunctional therapy. Other therapeutic options would be the hypoglossal implant or myotonic drugs such as desimipramine [51] or atomox­etine/oxybutynin [52, 53].
7
1.5.3 Loop Gain
After an obstructive event, there is a hyperventilation of a variable amplitude that depends on the individual. An elevated response to hypoxia and hypercapnia sec­ondary to apnea due to hypersensitivity of the chemoreceptors will lead to hyper­ventilation, decreased PaCO2 and the efferent impulse of the respiratory centers that will give an excessive response (very often present in the patients with severe OSA) and that will determine the instability of the respiratory system, in an increase in collapsibility and therefore favor the appearance of new obstructive apneas. Alternatively, postapnea hyperventilation can decrease PaCO2 and favor central apneas, which explains the coexistence of obstructive and central episodes in the same patient [32].
The sensitivity of the respiratory center can be quantied as the increase in ven­tilation in response to an alteration and return to homeostasis (loop gain). Therefore, a high loop gain is considered a negative aspect of UA collapsibility, while a low loop gain, by stabilizing respiration, can prevent the collapse of the UA and is there­fore considered positive. One-third of OSA patients are considered to have increased loop gain. Like the concept of decreased muscle efciency, it may be especially important in patients with mild-moderate OSA.
In cases like these, CPAP may not be effective [55], and there will be a need for other therapeutic options like respiratory re-education [49], additional oxygen ther­apy [55], or UA surgery [56].
1.5.4 Awakening Threshold
Apneas produce a transient or arousal awakening that creates the characteristic frag­mentation of sleep but favors the opening of the UA due to muscle activation. However, despite this effect, which has been considered protective until now, it has been shown that it can have a harmful effect for the patient. Awakening produces hyperventilation that can promote ventilatory instability and thus promote collapse. Each person has a different threshold for awakening, which can change depending on the stage of sleep. Usually, the N3 phase has a high wake-up threshold, implying
8
https://t.me/medicina_free
P. M. Baptista and G. P. Mayor
little respiratory variability and, as has been explained, greater activation of the UA muscles; therefore, fewer obstructive events occur. Thus, in general, a high arousal threshold is considered protective of the UA’s patency.
This is why, in some cases of OSA, mild hypnotics such as zopiclone or zolpi­dem can reduce the awakening threshold without modifying muscle tone [57].
1.6 From Phenotypes toEndotypes
Although initially described by Eckert as phenotypes, in OSA, there are underlying endotypes following the PALM (P
-arousal-loop-muscle) classication, which are
crit
the ones that will determine the most appropriate treatment for each patient, follow­ing increasingly personalized methods.
As we determine each patient’s endotype, we can offer a more precise and per­sonalized treatment, increasing adherence to CPAP and the supply of surgical and pharmacological treatments.
However, for this personalized approach, it is necessary to determine the P
crit
, the loop gain and the awakening threshold through certain studies that, at this moment, may be complex [5863].
1.7 Factors Defining Severity ofOSA
In OSA, the most widely accepted marker of the severity of disease is the apnea– hypopnea index (AHI), which represents the number of apneas and hypopneas per hour of sleep. The AHI is used not only to diagnose OSA (AHI>ve events/h together with daytime hypersomnia or other clinical manifestations) but also to classify the severity of the condition: mild OSA (AHI between 5 and 15), moderate OSA (AHI between 16 and 29) and severe OSA (AHI equal to or greater than 30).
It has been argued that this classication is arbitrary because there are scarce data to assess the relationship between AHI and the importance of daytime signs and symptoms. However, the usefulness of AHI as a predictor of cardiovascular morbid­ity and mortality has recently been demonstrated in long-term cohort studies [6470].
Oxygen desaturation, sleep interruption and total sleep time are important patho­logical parameters associated with apnea episodes. However, it is possible that these factors could serve as biomarkers of OSA severity, but there is still little data in the literature. However, until a specic “pattern marker” is widely accepted, the AHI can be considered the best option to dene the severity of OSA as sleep-disordered breathing.
OSA is considered part of an uninterrupted pathophysiological process in which the upper airway (UAV) presents a high resistance to airow [71] (Fig.1.3). Initially, this dysfunction does not present symptoms or manifests through snoring (suscepti­bility stage). Subjects predisposed to develop OSA probably have a high burden of
1 Introduction
https://t.me/medicina_free
9
Fig. 1.3 Observe the smaller airway in the right gure of a patient with OSA compared to a nor­mal patient, due to collapse of the airway, enlarged palate and tongue
susceptibility of unknown origin. As individuals age and reach adulthood, in addi­tion to weight gain, epigenetic factors may accentuate the collapsibility of the UA.
In the presymptomatic stage, snoring worsens and nocturnal apneas appear; however, the individual may not report any limitations in his daily activities.
If there isn’t any interruption, the patient develops nocturnal clinical manifesta­tions (e.g., nonpositional snoring, bed partner reported apneas, nocturia) and day­time (morning headache, asthenia, excessive sleepiness) that are increasingly disabling (stage of the clinical disease). At this phase, comorbidities may develop at an early age compared to populations without OSA, in a context that we can con­sider accelerated aging. If the illness is not identied and treated, the natural evolu­tion is directed toward disability and premature death (recovery stage, disability or death), mainly due to cardiovascular problems.
Most adults with OSA are overweight or obese [72]. Obesity is related to decreased thoracic cage distention capacity, reduced lung volumes and increased upper airway resistance. Furthermore, cervical fat also facilitates the collapse of the upper airway during sleep. These factors increase the frequency and duration of nocturnal respiratory events. On the other hand, there is a linear relationship between body weight and AHI.However, it has been mentioned that since obesity itself leads
10
https://t.me/medicina_free
Fig. 1.4 Relationship between OSA, obesity and sleep disorders
P. M. Baptista and G. P. Mayor
to increased cardiovascular morbidity and mortality, it is most likely that excess weight and not the AHI value is responsible for the increased morbidity and mortal­ity in patients with OSA.
The prevalence of OSA in obese patients exceeds 30%; in cases of morbid obe­sity, it reaches 98%. It is estimated that a 10% weight gain increases the AHI by 32%, while a 10% reduction can improve the AHI by 26% [72]. Numerous studies have shown that weight gain is related to the development of OSA or its worsening [73]. Obesity aggravates OSA because the increase in fat in the UA favors the col­lapse of its lumen. The cervical circumference has been shown to be a better predic­tor of OSA severity than body mass index (BMI); also, adults with OSA have high levels of leptin (a satiating hormone in thin individuals) and ghrelin (appetite­stimulating hormone) and lower levels of adiponectin (an anti-inammatory cyto­kine that increases insulin sensitivity). A vicious circle exists where obesity and OSA worsen each other (Fig.1.4).
The following chapters of this book will review in a comprehensive way the main medical consequences of suffering from OSA in adults in diverse elds of medicine.
1.8 Mortality
Death is the most determining “result” or nal effect of the natural history of any chronic medical entity. Premature death, however, comes to represent the sum of “unhealthy” risk factors that aggravate the progression of the index disease, in this case, OSA (Fig.1.5). In sleep medicine, some clinical signs or symptoms, such as drowsiness or snoring, are easy to measure in routine practice and the development of a clinical trial. However, cardiovascular events and death are subject to comorbid conditions that make it more challenging to establish the denitive role of OSA.